International Journal of General Medicine (May 2022)

Preliminary Screening of a Familial Tuberous Sclerosis Complex Pathogenic Gene

  • Wang Y,
  • Hu S,
  • Tan X,
  • Sang Q,
  • Shi P,
  • Wang C,
  • Sang D

Journal volume & issue
Vol. Volume 15
pp. 5247 – 5252

Abstract

Read online

Yuting Wang,1 SongNian Hu,2 XinYu Tan,2 Qingqing Sang,3 Peng Shi,3 Chun Wang,3 Daoqian Sang3 1Department of Neurology, The Third Affiliated Hospital of Anhui Medical University, Heifei, People’s Republic of China; 2State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of China; 3Department of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People’s Republic of ChinaCorrespondence: Daoqian Sang, Department of Neurology, The First Affiliated Hospital of Bengbu Medical College, 287, Changhuai Road, Bengbu, 233004, People’s Republic of China, Email [email protected]: The aim of this study was to screen the possible pathogenic genes of one family with tuberous sclerosis complexes (TSCs).Patients and Methods: All family members were examined through detailed clinical evaluations, auxiliary examinations and CT. Then, we selected five members from this TSC family as the test samples. They were analysed by a new exon group sequencing method. Single nucleotide polymorphisms (SNPs) were screened by using databases, such as dbSNP and HAPMAP, and then the candidate genes were selected. Genes were analysed, and finally, the most likely mutation sites were screened. The results were examined by Sanger sequencing.Results: In this TSC family, we identified c.913+2T>G, a splicing site mutation in the 9th intron region of TSC1. Family members without TSC did not have this mutation.Conclusion: The mutations in the intron regions cannot be ruled out as a pathogenic factor for TSC.Keywords: pathogenic genes, tuberous sclerosis complex, whole exon sequencing, intron mutation

Keywords